Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice ; volume:21 ; number:1 ; day:9 ; month:11 ; year:2023 ; pages:1-21 ; date:12.2023
Cell communication and signaling ; 21, Heft 1 (9.11.2023), 1-21, 12.2023
- Creator
-
Daei Sorkhabi, Amin
Komijani, Erfan
Sarkesh, Aila
Ghaderi Shadbad, Pedram
Aghebati-Maleki, Ali
Aghebati-Maleki, Leili
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12964-023-01289-9
- URN
-
urn:nbn:de:101:1-2024012911193945531423
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Daei Sorkhabi, Amin
- Komijani, Erfan
- Sarkesh, Aila
- Ghaderi Shadbad, Pedram
- Aghebati-Maleki, Ali
- Aghebati-Maleki, Leili
- SpringerLink (Online service)
Other Objects (12)
Advances in Prostate Cancer Immunotherapies
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
Immune biological rationales for the design of combined radio- and immunotherapies
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
Immunotherapies in solid tumors
Immunotherapies in rare cancers
Recent advances in amyotrophic lateral sclerosis
Neurotoxicity of novel cancer immunotherapies
Emerging Immunotherapies for Parkinson Disease
Implantable Biomaterials for Cancer Immunotherapies
Poxvirus immunotherapies in combination with immune checkpoint inhibitors synergize to eliminate tumors in a mouse tumor model
Current status of chimeric antigen receptor engineered T cell-based and immune checkpoint blockade-based cancer immunotherapies
Advances in Prostate Cancer Immunotherapies
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
Immune biological rationales for the design of combined radio- and immunotherapies
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
Immunotherapies in solid tumors
Immunotherapies in rare cancers
Recent advances in amyotrophic lateral sclerosis
Neurotoxicity of novel cancer immunotherapies
Emerging Immunotherapies for Parkinson Disease
Implantable Biomaterials for Cancer Immunotherapies
Poxvirus immunotherapies in combination with immune checkpoint inhibitors synergize to eliminate tumors in a mouse tumor model
Current status of chimeric antigen receptor engineered T cell-based and immune checkpoint blockade-based cancer immunotherapies
Advances in Prostate Cancer Immunotherapies
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
Immune biological rationales for the design of combined radio- and immunotherapies
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
Immunotherapies in solid tumors
Immunotherapies in rare cancers
Recent advances in amyotrophic lateral sclerosis
Neurotoxicity of novel cancer immunotherapies
Emerging Immunotherapies for Parkinson Disease
Implantable Biomaterials for Cancer Immunotherapies
Poxvirus immunotherapies in combination with immune checkpoint inhibitors synergize to eliminate tumors in a mouse tumor model